Journal article icon

Journal article

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Abstract:

The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222) vaccine in the United Kingdom was analyzed to determine the antibody levels associated with protection against SARS-CoV-2. Binding and neutralizing antibodies at 28 days after the second dose were measured in infected and noninfected vaccine recip...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41591-021-01540-1

Authors


More by this author
Role:
Author
ORCID:
0000-0003-0686-5091
Expand authors...

Contributors

DH | National Institute for Health Research (NIHR) More from this funder
Publisher:
Springer Nature Publisher's website
Journal:
Nature Medicine Journal website
Volume:
27
Pages:
2032-2040
Place of publication:
United States
Publication date:
2021-09-29
Acceptance date:
2021-09-14
DOI:
EISSN:
1546-170X
ISSN:
1078-8956
Pmid:
34588689
Language:
English
Keywords:
Pubs id:
1197861
Local pid:
pubs:1197861
Deposit date:
2021-10-15

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP